enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by enVVeno Medical Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $123.31 in total
- Insiders trading
- 1
- Net value
- −$123.31
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for enVVeno Medical Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Duhay Francis | Director | 2,351 | Sep 14, 2026 | 5 |
| Berman Robert Andrew | Chief Executive Officer | 222,236 | Dec 18, 2025 | 1 |
| Glickman Marc H. | SVP & Chief Medical Officer | 101,600 | Dec 18, 2025 | 1 |
| Alavi Hamed | Chief Technology Officer | 0 | Dec 18, 2025 | 1 |
| Jenusaitis Matthew | Director | 16,545 | Dec 15, 2025 | 1 |
| Shrivastava Sanjay | Director | 9,288 | Dec 15, 2025 | 1 |
| Gray Robert | Director | 11,155 | Dec 15, 2025 | 1 |
| Bright Jennifer | Chief Financial Officer | – | May 20, 2025 | 0 |
| Glynn Craig | Chief Financial Officer | 50,000 | Dec 7, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 (view filing)6:56 PM ET | Sep 11 | 3 days | Duhay FrancisDirector | SSale | −11 | $11.21 | −$123.31 | −0.5%2.35K after | 10b5-1 |
| Jun 12, 2026 (view filing) | Jun 11 | 1 day | Duhay FrancisDirector | SSale | −140 | $10.31 | −$1.44K | −5.6%2.36K after | 10b5-1 |
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Duhay FrancisDirector | SSale | −140 | $11.52 | −$1.61K | −5.3%2.50K after | 10b5-1 |
| Dec 12, 2025 (view filing)4:40 PM ET | Dec 11 | 1 day | Duhay FrancisDirector | SSale | −4.90K | $0.3556 | −$1.74K | −5.0%92.5K after | 10b5-1 |
| Sep 17, 2025 (view filing) | Sep 15 | 2 days | Duhay FrancisDirector | SSale | −4.90K | $0.83 | −$4.07K | −4.8%97.4K after | 10b5-1 |
| Jan 3, 2025 (view filing) | Dec 31, 2024 | 3 days | Duhay FrancisDirector | PPurchase | +81.4K | $3.07 | +$250.0K | +389.4%102.3K after | |
| Jan 2, 2025 (view filing) | Dec 31, 2024 | 2 days | Gray RobertDirector | PPurchase | +3.50K | $2.94 | +$10.3K | +45.7%11.2K after | |
| Dec 26, 2024 (view filing) | Dec 24 | 2 days | Shrivastava SanjayDirector | PPurchase | +5.40K | $2.90 | +$15.7K | +138.9%9.29K after | |
| Dec 23, 2024 (view filing) | Dec 19 | 4 days | Jenusaitis MatthewDirector | PPurchase | +9.62K | $2.53 | +$24.3K | +138.9%16.5K after | |
| Dec 19, 2024 (view filing) | Dec 19 | Same day | Berman Robert AndrewChief Executive Officer | PPurchase | +12.0K | $2.55 | +$30.6K | +5.7%222.2K after | |
| Mar 15, 2024 (view filing) | Mar 13 | 2 days | Alavi HamedChief Technology Officer | SSale | −8.33K | $6.22 | −$51.8K | −100.0%0 after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Duhay FrancisDirector | PPurchase | +7.75K | $6.14 | +$47.6K | +58.9%20.9K after | |
| Jul 1, 2022 (view filing) | Jun 30 | 1 day | Shrivastava SanjayDirector | PPurchase | +1.00K | $3.85 | +$3.85K | +34.6%3.89K after | |
| Jun 28, 2022 (view filing) | Jun 27 | 1 day | Berman Robert AndrewChief Executive Officer | PPurchase | +2.50K | $3.80 | +$9.50K | +1.2%210.2K after | |
| Nov 19, 2021 (view filing) | Nov 19 | Same day | Berman Robert AndrewCEO | PPurchase | +2.00K | $7.43 | +$14.9K | +34.9%7.74K after | |
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Berman Robert AndrewCEO | PPurchase | +2.00K | $7.87 | +$15.7K | +53.5%5.74K after | |
| Aug 27, 2021 (view filing) | Aug 25 | 2 days | Jenusaitis MatthewDirector | PPurchaseCommon Stock, $$0.00001 par value | +1.30K | $7.70 | +$10.0K | +36.7%4.84K after |